Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cholecystokinin B receptor (CCKBR) is a G protein-coupled receptor that binds cholecystokinin (CCK) and gastrin. It is primarily found in the central nervous system and gastrointestinal tract. Upon ligand binding, the receptor couples to G proteins, mainly Gq/G11, activating phospholipase C signaling pathways. It plays a role in anxiety, feeding behavior, memory, nociception, gastric acid secretion, and dopamine activity. Altered expression is seen in some cancers and polymorphisms are linked to anxiety and hallucinations.
Agonists activate the receptor leading to G protein activation, mainly Gq/G11, which activate phospholipase C signaling pathways leading to intracellular calcium mobilization. Antagonists block the receptor preventing activation by endogenous ligands.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholecystokinin B Receptor (CCKBR).